TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CVKD

Cadrenal Therapeutics, Inc.

Healthcare · Biotechnology

1.20$ -9.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CVKD
Line item 2022 2023 2024 2025
– 0.00 0.00 0.00
0.00 0.00 0.00 –
0.00 0.00 0.00 –
0.51 4.70 3.45 2.06
– 4.09 5.54 4.69
3.48 8.79 8.99 6.75
-3.48 -8.79 -8.99 -6.75
0.14 0.02 0.00 –
-8.66 -9.63 -8.73 -6.64
0.00 -0.19 – –
-8.66 -9.63 -8.73 -6.64
-8.52 -9.60 -8.73 -6.64

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?